Value
7.4/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 1.7 |
| P/S | 8.7 |
| EV/EBITDA | 3.8 |
| Fwd P/E | 8.3 |
| PEG | 10.0 |
| Analyst target | 9.0 |
- ▸Forward P/E: 14.1x
- ▸PEG: 0.29
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Celsius Holdings combines a wide economic moat, a perfect Piotroski financial health score of 9 out of 9, 138% year-over-year revenue growth, and four consecutive earnings beats averaging over 55% surprise — exceptional fundamentals that are currently trapped in a confirmed price downtrend where the moving average slope is declining at 6.6% per month; the fundamental case is compelling for patient capital, but the technical picture calls for waiting on momentum stabilization before adding to exposure.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
A wide economic moat alongside a perfect Piotroski financial health score of 9 out of 9 signals that competitive advantages are durable and the balance sheet is in excellent condition — a rare combination that distinguishes the company as a high-quality franchise in its category. Quality breakdown | Piotroski F-Score remains at 8 or above and gross margin holds steady or expands over the next 4 quarters, confirming the moat is not being competed away. | →Stable |
| CounterA wide-moat designation reflects historical competitive positioning; in a high-growth consumer category, shelf distribution and brand advantages can erode faster than financial health indicators suggest if a better-capitalized competitor scales aggressively or distribution is curtailed. | ||
The stock trades below the 200-day moving average with a slope declining at 6.6% per month — a confirmed downtrend — despite rising on-balance volume that indicates buyers are absorbing shares; the technical picture warrants caution on near-term entry timing even as the fundamental case remains intact. Momentum breakdown | RSI recovers above 50 and price closes above the 200-day moving average for more than 20 consecutive trading days, confirming that the downtrend has stabilized. | →Stable |
| CounterThe declining moving average slope of 6.6% per month is a severe reading in a defensive consumer name; if revenue growth decelerates at the same time, the technical breakdown could be confirmed rather than reversed, making the current volume accumulation signal premature. | ||
Revenue has expanded at 138% year over year, and the company holds the leading growth position within its industry peer group — a combination that, at a forward earnings multiple of 14.1 times and a price-earnings-to-growth ratio of 0.29, implies the market is pricing the growth at a meaningful discount to its rate of expansion. Growth breakdown | Revenue growth sustains above 50% year over year for at least 2 consecutive quarters while gross margin holds or expands, confirming the growth is high-quality and not being purchased through margin sacrifice. | →Stable |
| CounterThe law of large numbers will compress the 138% growth rate as the revenue base expands; if growth decelerates toward 30-40%, the forward multiple could re-rate upward and erode the apparent valuation discount that currently supports the bull case. | ||
The company has beaten consensus estimates in all four of the last four quarters, with an average surprise of over 55% — a record of consistently under-promising and over-delivering that signals management's guidance may be set conservatively relative to actual business momentum. Earnings | At least 3 of the next 4 quarters produce positive EPS surprises exceeding 15%, confirming the pattern of conservative guidance discipline is a sustainable feature of the operating model. | →Stable |
| CounterThe average 55% beat streak has decelerated in magnitude across the four observations, from the oldest quarter's 93% surprise down toward the most recent quarter's 40%; analyst estimates may be catching up to reality, which could compress future surprise magnitude and make the streak harder to maintain at historically elevated levels. | ||
At current prices, 89.7% of headroom remains to the analyst consensus target with a reward-to-risk ratio of roughly 12.8-to-1 — a geometry that reflects a high-conviction fundamental setup and, if the downtrend stabilizes, would represent a materially attractive entry point. Price targets | Price reaches within 20% of the $54.51 analyst consensus target within 18 months, validating the asymmetric setup as fundamentals close the gap. | →Stable |
| CounterA rich reward-to-risk ratio driven by a large analyst consensus target can persist unfulfilled indefinitely if the catalyst required to bridge the gap — trend reversal, multiple re-rating, earnings acceleration — does not materialize within the investment horizon; the target itself could be revised lower as growth decelerates. | ||
CounterA wide-moat designation reflects historical competitive positioning; in a high-growth consumer category, shelf distribution and brand advantages can erode faster than financial health indicators suggest if a better-capitalized competitor scales aggressively or distribution is curtailed.
CounterThe declining moving average slope of 6.6% per month is a severe reading in a defensive consumer name; if revenue growth decelerates at the same time, the technical breakdown could be confirmed rather than reversed, making the current volume accumulation signal premature.
CounterThe law of large numbers will compress the 138% growth rate as the revenue base expands; if growth decelerates toward 30-40%, the forward multiple could re-rate upward and erode the apparent valuation discount that currently supports the bull case.
CounterThe average 55% beat streak has decelerated in magnitude across the four observations, from the oldest quarter's 93% surprise down toward the most recent quarter's 40%; analyst estimates may be catching up to reality, which could compress future surprise magnitude and make the streak harder to maintain at historically elevated levels.
CounterA rich reward-to-risk ratio driven by a large analyst consensus target can persist unfulfilled indefinitely if the catalyst required to bridge the gap — trend reversal, multiple re-rating, earnings acceleration — does not materialize within the investment horizon; the target itself could be revised lower as growth decelerates.
| Component | Sub-score |
|---|---|
| P/E | 1.7 |
| P/S | 8.7 |
| EV/EBITDA | 3.8 |
| Fwd P/E | 8.3 |
| PEG | 10.0 |
| Analyst target | 9.0 |
| Component | Sub-score |
|---|---|
| ROE | 2.7 |
| ROA | 7.6 |
| Gross margin | 6.1 |
| Op margin | 7.9 |
| Net margin | 2.9 |
| Current ratio | 6.3 |
| FCF quality | 7.1 |
| Moat | 7.9 |
| Piotroski F | 10.0 |
| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
| EPS growth | 10.0 |
| Component | Sub-score |
|---|---|
| RSI | 4.5 |
| MACD | 8.1 |
| OBV | 1.0 |
| MA position | 1.0 |
| Volume | 0.0 |
| Component | Sub-score |
|---|---|
| LLM sentiment | 5.2 |
| Analyst rating | 7.5 |
| Price target | 10.0 |
| Component | Sub-score |
|---|---|
| materiality | 5.5 |
| holder change | 5.1 |
| Component | Sub-score |
|---|---|
| value rank | 2.7 |
| quality rank | 1.2 |
| growth rank | 9.2 |
| Component | Sub-score |
|---|---|
| bollinger | 6.0 |
| support resistance | 7.7 |
| 52w position | 0.0 |
| Component | Sub-score |
|---|---|
| short interest | 3.7 |
| days to cover | 7.8 |
| volatility | 0.0 |
| put call | 6.0 |
| implied vol | 1.7 |
| max pain risk | 3.0 |
| beta | 7.6 |
| debt equity | 9.1 |
| news risk | 6.0 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| news activity | 6.0 |
Maintain position. Not compelling to add more.
L4:PATH_F_HOLDnone
SetupRECOVERY — Death cross but MACD improving, RSI 57
EdgeNO_EDGE — No clear edge identified
SuitabilityMODERATE — Balanced profile
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: ASYMMETRY:8.8>=1.5. Top dim: Growth at 10.0; weakest: Momentum at 2.9. No conviction either direction.
The strongest dimensions are Growth at 10.0, Sentiment at 7.5, and Value at 7.4; the weakest are Momentum at 2.9, Peer rank at 3.3, and Technical at 4.6. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of 8.80 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifPiotroski F-Score falls below 7 for 2 consecutive quarters.
Trip ifRevenue growth falls below 30% year over year for 2 consecutive quarters.
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
Trip ifRSI rises above 50 and price closes above the 200-day moving average for more than 20 consecutive trading days.
Trip ifAnalyst consensus target falls below $40 from the current $54.51.